Imunon Inc expected to post a loss of 36 cents a share - Earnings Preview

Imunon Inc IMNN.OQ IMNN.O is expected to show no change in quarterly revenue when it reports  results on February 27 for the period ending December 31 2024

​LSEG's mean analyst estimate for Imunon Inc is for a loss of 36 cents per share.

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 4 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."

The mean earnings estimate of analysts was unchanged in the last three months. ​

Wall Street's median 12-month price target for Imunon Inc is $12.00​, above​ its last closing price of $0.86. ​​​

Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER ENDINGSTARMINESMARTESTIMATE®LSEG IBES ESTIMATEACTUALBEAT, MET, MISSEDSURPRISE %
Sep. 30 2024-0.43-0.40-0.34Beat14.5
Jun. 30 2024-0.51-0.54-0.51Beat6.1
Mar. 31 2024-0.56-0.57-0.52Beat8.2​
Dec. 31 2023-0.41-0.52Missed-26.8
​​Sep. 30 2023-0.66-0.66-0.37Beat43.9
Jun. 30 2023-0.70-0.70-0.61Beat13.5​
Mar. 31 2023-0.66-0.66-0.68Missed-2.5
Dec. 31 2022-0.85-1.61Missed-89.4
This summary was machine generated February 25 at 13:45 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

Recent news on Imunon

See all news